A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis
-
- Yasmina Bauer
- Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
-
- John Tedrow
- Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;
-
- Simon de Bernard
- AltraBio, Lyon, France; and
-
- Magdalena Birker-Robaczewska
- Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
-
- Kevin F. Gibson
- Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;
-
- Brenda Juan Guardela
- Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;
-
- Patrick Hess
- Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
-
- Axel Klenk
- Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
-
- Kathleen O. Lindell
- Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;
-
- Sylvie Poirey
- Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
-
- Bérengère Renault
- Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
-
- Markus Rey
- Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
-
- Edgar Weber
- Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
-
- Oliver Nayler
- Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
-
- Naftali Kaminski
- Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;
収録刊行物
-
- American Journal of Respiratory Cell and Molecular Biology
-
American Journal of Respiratory Cell and Molecular Biology 52 (2), 217-231, 2015-02
American Thoracic Society